Read the docs
TI-2022-23464 Aliases CVE-2022-47376GHSA-h3m9-vw67-pc8x

Insufficiently protected credentials in Alaris Infusion Central

Priority LOW 33CWE-257Published · Updated

Key facts

Attack vector
Local
Privileges required
Low
User interaction
None
Attack complexity
Low
Impact type
Information disclosure
Confidentiality · integrity · availability
High · High · Low
Fix status
No fix listed

Attack profile from CVSS 3.1 · CISA ADP. Fix status from CNA. Impact type from CWE-522.

Summary

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.

Why it matters now

Exploitation None reported CISA SSVC · not in CISA KEV
EPSS 0.00162 5th percentileScored 2026-11-07
Fix No fix listed No fixed version in the sources yet

SSVC decision points

CISA ADP · SSVC 2.0.3

Exploitation
None
Automatable
No
Technical impact
Total

The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.

Affected products

VendorProductAffected versionsFixed inStatusSource
—Alaris Infusion Centralup to 1.3.2—No fix listedCNA
  • Alaris Infusion Central Vendor— Affected up to 1.3.2 Fixed in — No fix listed CNA

CPE configurations NVD · 1

CPEVersionsRoleVendor
cpe:2.3:a:bd:alaris_infusion_central:*:*:*:*:*:*:*:*1.1 – 1.3.2VulnerableBecton, Dickinson and Company (BD)

Remediation

No fixed version listed by the sources yet.

Timeline

  1. 2026-10-02 Threatist record created from CVE-2022-47376
  2. 2026-10-03 Alias added: GHSA-h3m9-vw67-pc8x

References

Advisory 1

Sources

This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences